Michael Mertzman
About Michael Mertzman
Michael Mertzman is a Research Scientist II at Bristol-Myers Squibb, specializing in the synthesis, isolation, and characterization of drug candidate compounds for Immunology programs.
Title at Bristol-Myers Squibb
Michael Mertzman holds the position of Research Scientist II at Bristol-Myers Squibb. He works out of the Lawrenceville, NJ location where he focuses on drug candidate compounds for Immunology programs.
Previous Roles in Pharmaceuticals
Michael Mertzman has a robust background in the pharmaceutical industry, previously holding positions at Lexicon Pharmaceuticals and Gilead Sciences. At Lexicon Pharmaceuticals, he was a Principal Research Associate on two separate occasions, from 1999 to 2004 and again in 2010 for four months. Between these periods, he worked at Gilead Sciences as a Sr. Research Associate II, from 2004 to 2010.
Education and Chemistry Expertise
Michael Mertzman studied Chemistry at La Salle University, where he obtained his Bachelor of Science (B.S.) degree. His academic tenure at La Salle University spanned from 1988 to 1992. His education laid a strong foundation for his specialized role in synthesizing, isolating, and characterizing drug candidate compounds.
Experience in Drug Candidate Compounds
Since joining Bristol-Myers Squibb in April 2011, Michael Mertzman has specialized in the synthesis, isolation, and characterization of drug candidate compounds, specifically for Immunology programs. His role involves a detailed focus on advancing drug candidates through various developmental stages.